{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T05:01:46Z","timestamp":1663563706212},"reference-count":20,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2019.1862","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T11:51:06Z","timestamp":1558439466000},"source":"Crossref","is-referenced-by-count":2,"title":["Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report"],"prefix":"10.3892","author":[{"given":"Yoshinori","family":"Iwata","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Matsuhashi","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonari","family":"Suetsugu","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Fukada","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Yasufuku","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeharu","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Tanahashi","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Gifu 501\u20111194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"key20200713202502_b1-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJM200002033420501","article-title":"A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group","volume":"342","author":"Imagawa","year":"2000","journal-title":"N Engl J Med"},{"key":"key20200713202502_b2-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"key":"key20200713202502_b3-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/ncpendmet0351","article-title":"Fulminant type 1 diabetes: A novel clinical entity requiring special attention by all medical practitioners","volume":"3","author":"Hanafusa","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key20200713202502_b4-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00125-004-1626-x","article-title":"Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus","volume":"48","author":"Imagawa","year":"2005","journal-title":"Diabetologia"},{"key":"key20200713202502_b5-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2337\/dc08-0280","article-title":"Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients","volume":"31","author":"Kawasaki","year":"2008","journal-title":"Diabetes Care"},{"key":"key20200713202502_b6-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","article-title":"Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis","volume":"340","author":"Fabris","year":"1992","journal-title":"Lancet"},{"key":"key20200713202502_b7-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0168-8227(00)00143-1","article-title":"A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy","volume":"49","author":"Uto","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"key20200713202502_b8-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nm.3042","article-title":"Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes","volume":"19","author":"Diana","year":"2013","journal-title":"Nat Med"},{"key":"key20200713202502_b9-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s12185-016-2101-4","article-title":"Fulminant type I diabetes mellitus associated with nivolumab in a patient with relapsed classical Hodgkin lymphoma","volume":"105","author":"Munakata","year":"2017","journal-title":"Int J Hematol"},{"key":"key20200713202502_b10-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/jdi.12531","article-title":"Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy","volume":"7","author":"Okamoto","year":"2016","journal-title":"J Diabetes Investig"},{"key":"key20200713202502_b11-mco-0-0-1862","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2337\/dc14-2349","article-title":"Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy","volume":"38","author":"Hughes","year":"2015","journal-title":"Diabetes Care"},{"key":"key20200713202502_b12-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","article-title":"Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy","volume":"60","author":"Hofmann","year":"2016","journal-title":"Eur J Cancer"},{"key":"key20200713202502_b13-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.2337\/dc15-1331","article-title":"Anti-PD1 pembrolizumab can induce exceptional fulminant type 1 diabetes","volume":"38","author":"Gaudy","year":"2015","journal-title":"Diabetes Care"},{"key":"key20200713202502_b14-mco-0-0-1862","first-page":"2185","article-title":"UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice","volume":"5","author":"Yonekura","year":"1999","journal-title":"Clin Cancer Res"},{"key":"key20200713202502_b15-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20200713202502_b16-mco-0-0-1862","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1634\/theoncologist.3-3-155","article-title":"UFT plus oral leucovorin: A new oral treatment for colorectal cancer","volume":"3","author":"Hoff","year":"1998","journal-title":"Oncologist"},{"key":"key20200713202502_b17-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.1990.03450110090034","article-title":"Adjuvant therapy for patients with colon and rectal cancer","volume":"264","author":"NIH consensus conference","year":"1990","journal-title":"JAMA"},{"key":"key20200713202502_b18-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","article-title":"American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer","volume":"22","author":"Benson","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20200713202502_b19-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1093\/annonc\/mds236","article-title":"ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making","volume":"23","author":"Schmoll","year":"2012","journal-title":"Ann Oncol"},{"key":"key20200713202502_b20-mco-0-0-1862","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2169\/internalmedicine.54.3413","article-title":"The development of fulminant type 1 diabetes during chemotherapy for rectal cancer","volume":"54","author":"Adachi","year":"2015","journal-title":"Intern Med"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T10:16:33Z","timestamp":1663496193000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2019.1862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.3892\/mco.2019.1862","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]}}}